BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35729549)

  • 1. Impact of an electronic medical record-based automated screening program for critical congenital heart disease: Emirates Health Services, United Arab Emirates.
    Zarouni SA; Mheiri NMA; Blooshi KA; Serkal YA; Preman N; Naqvi SA; Khan Y
    BMC Med Inform Decis Mak; 2022 Jun; 22(1):165. PubMed ID: 35729549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn Screening for Critical Congenital Heart Disease in a Low-Resource Setting; Research Protocol and Preliminary Results of the Tanzania Pulse Oximetry Study.
    Majani N; Chillo P; Slieker MG; Sharau G; Mlawi V; Mongella S; Nkya D; Khuboja S; Kwesigabo G; Kamuhabwa A; Janabi M; Grobbee D
    Glob Heart; 2022; 17(1):32. PubMed ID: 35837363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional implementation of newborn screening for critical congenital heart disease screening in Abu Dhabi.
    Al Mazrouei SK; Moore J; Ahmed F; Mikula EB; Martin GR
    Pediatr Cardiol; 2013 Aug; 34(6):1299-306. PubMed ID: 23532467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the diagnostic gap: statewide incidence of undiagnosed critical congenital heart disease before newborn screening with pulse oximetry.
    Mouledoux JH; Walsh WF
    Pediatr Cardiol; 2013 Oct; 34(7):1680-6. PubMed ID: 23595939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal and newborn screening for critical congenital heart disease: findings from a nursery.
    Johnson LC; Lieberman E; O'Leary E; Geggel RL
    Pediatrics; 2014 Nov; 134(5):916-22. PubMed ID: 25287457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse oximetry findings in newborns with antenatally diagnosed congenital heart disease.
    Mawson IE; Babu PL; Simpson JM; Fox GF
    Eur J Pediatr; 2018 May; 177(5):683-689. PubMed ID: 29404717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Critical Congenital Heart Disease in Newborns.
    Bruno CJ; Havranek T
    Adv Pediatr; 2015 Aug; 62(1):211-26. PubMed ID: 26205115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Pulse Oximetry Pulsatility Index Screening for Critical Congenital Heart Disease.
    Rasmussen M; Suttner D; Poeltler D; Katheria AC
    Am J Perinatol; 2024 May; 41(S 01):e545-e549. PubMed ID: 35858650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early screening for critical congenital heart defects in asymptomatic newborns in Bursa province.
    Özalkaya E; Akdağ A; Şen I; Cömert E; Melek Yaren H
    J Matern Fetal Neonatal Med; 2016; 29(7):1105-7. PubMed ID: 25902399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Critical Congenital Heart Disease.
    Oster ME; Kochilas L
    Clin Perinatol; 2016 Mar; 43(1):73-80. PubMed ID: 26876122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse oximetry screening for critical congenital heart disease: a comparative study of cohorts over 11 years.
    Banait N; Ward-Platt M; Abu-Harb M; Wyllie J; Miller N; Harigopal S
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2064-2068. PubMed ID: 30332903
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country.
    Jawin V; Ang HL; Omar A; Thong MK
    PLoS One; 2015; 10(9):e0137580. PubMed ID: 26360420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using State Birth Defects Registries to Evaluate Regional Critical Congenital Heart Disease Newborn Screening.
    Case AP; Miller SD; McClain MR
    Birth Defects Res; 2017 Nov; 109(18):1414-1422. PubMed ID: 29152920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal pulse oximetry screening improves detecting of critical congenital heart disease.
    Ma XJ; Huang GY
    Chin Med J (Engl); 2013 Jul; 126(14):2736-40. PubMed ID: 23876906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.
    Peterson C; Ailes E; Riehle-Colarusso T; Oster ME; Olney RS; Cassell CH; Fixler DE; Carmichael SL; Shaw GM; Gilboa SM
    JAMA Pediatr; 2014 Apr; 168(4):361-70. PubMed ID: 24493342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse Oximetry Screening for Critical Congenital Heart Defects.
    Wood J
    Neonatal Netw; 2015; 34(3):156-64. PubMed ID: 26802391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community.
    Miller KK; Vig KS; Goetz EM; Spicer G; Yang AJ; Hokanson JS
    J Perinatol; 2016 Dec; 36(12):1088-1091. PubMed ID: 27583398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Saga of Pulse Oximetry Screening for Critical Congenital Heart Disease in Israel: A Historical Perspective.
    Bin-Nun A; Hammerman C; Mimouni FB; Wasserteil N; Kasirer YM
    Isr Med Assoc J; 2021 Apr; 23(4):229-232. PubMed ID: 33899355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse Oximetry Overestimates Oxyhemoglobin in Neonates with Critical Congenital Heart Disease.
    Murphy D; Pak Y; Cleary JP
    Neonatology; 2016; 109(3):213-8. PubMed ID: 26800085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure screening for critical congenital heart disease in neonates.
    Boelke KL; Hokanson JS
    Pediatr Cardiol; 2014 Dec; 35(8):1349-55. PubMed ID: 24898292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.